Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Preferred Shares (2021 - 2025)

Bioadaptives' Preferred Shares history spans 5 years, with the latest figure at $100.0 for Q4 2025.

  • Quarterly results put Preferred Shares at $100.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $100.0 (changed 0.0% YoY), and the annual figure for FY2025 was $100.0, changed 0.0%.
  • Preferred Shares for Q4 2025 was $100.0 at Bioadaptives, roughly flat from $100.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $335.0 in Q1 2024 to a low of $1.0 in Q4 2023.
  • The 5-year median for Preferred Shares is $160.0 (2021), against an average of $159.81.
  • The sharpest move saw Preferred Shares skyrocketed 9900.0% in 2024, then tumbled 99.66% in 2025.
  • Year by year, Preferred Shares stood at $160.0 in 2021, then changed by 0.0% to $160.0 in 2022, then crashed by 99.38% to $1.0 in 2023, then skyrocketed by 9900.0% to $100.0 in 2024, then changed by 0.0% to $100.0 in 2025.
  • According to Business Quant data, Preferred Shares over the past three periods came in at $100.0, $100.0, and $1.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.